title: A case of primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma.
authors.affiliation: Department of Dermatology.
authors.forename: Suchun
authors.initials: S
authors.lastname: Hou
authors.affiliation: Department of Dermatology.
authors.forename: Xiaoming
authors.initials: X
authors.lastname: Liu
authors.affiliation: Department of Pathology, Hong Kong University Shenzhen Hospital, Shenzhen 518000, China.
authors.forename: Junru
authors.initials: J
authors.lastname: Liu
authors.affiliation: Department of Dermatology.
authors.forename: Zhenying
authors.initials: Z
authors.lastname: Zhang
authors.affiliation: Department of Dermatology.
authors.forename: Bin
authors.initials: B
authors.lastname: Wang
authors.affiliation: Department of Dermatology.
authors.forename: Changxu
authors.initials: C
authors.lastname: Han
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000473:pathology*; D005142:Eyelid Neoplasms / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local; D011241:Prednisone / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*
chemical_list: D016898:Interferon-alpha; C000621575:interferon alfa-1b, human; D011241:Prednisone; D008727:Methotrexate